Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Izzy who wrote (2885)	11/19/1997 2:37:00 PM
From: Joe E.	Respond to of 6136

<<Wouldn't the Australian and European approvals make the stock run (take off like a rocket >50) on the short term? Anyone else have any ideas. >> European approval probably would if officially announced, or if proclaimed by a respected analyst with a big investment company, instead of just rumored on the internet. I figure that a one quarter (calendar) advance in the timing of European approval would be worth roughly a dollar in the stock price. And an announcement today would be about one quarter ahead of the expected approval date. Approval in the EU seems certain, but the timing is not. IMO bureaucrats need to be able to kill off their fellow citizens to feel important, and delayed approval gives them a chance to do so without penalty.